The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Obesity is an independent risk factor for non‐alcoholic fatty liver disease: evidence from a meta‐analysis of 21 cohort studies
Abstract
Summary: Background: The association between obesity and nonalcoholic fatty liver disease (NAFLD) has not been fully quantified, and the magnitude of NAFLD risk associated with obesity is still unclear. A meta‐analysis of cohort studies was performed to elucidate the NAFLD risk associated with obesity. Methods: Pubmed, Web of Science and Embase were searched for cohort studies assessing NAFLD risk associated with obesity or increased body mass index (BMI). Relative risks (RRs) with 95% confidence intervals (95%CIs) were pooled using random‐effects model of meta‐analysis. Results: Twenty‐one cohort studies including 13 prospective studies and 8 retrospective studies were finally included. There were a total of 381,655 participants in the meta‐analysis. Compared with normal weight, obesity independently led to a 3.5‐fold increased risk of developing NAFLD (RR = 3.53, 95%CI 2.48 to 5.03, P < 0.001). Meta‐analysis also suggested an obvious dose‐dependent relationship between BMI and NAFLD risk (per 1‐unit increment in BMI: RR = 1.20, 95%CI 1.14 to 1.26, P < 0.001). Subgroup analyses further identified the robustness of the association above. No obvious risk of publication bias was observed. Conclusion: Obese individuals have a 3.5‐fold increased risk of developing NAFLD, and there is an obvious dose‐dependent relationship between BMI and NAFLD risk. © 2016 World Obesity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhou, Y. J., Li, Y. Y., Nie, Y. Q., Huang, C., & Cao, C. Y. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00571.x · Cited by 93
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072
Nonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · Hepatology · doi:10.1002/hep.24452 · Cited by 1,585
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062
Obesity accelerates epigenetic aging of human liver
Horvath, S., Erhart, W., Brosch, M., Ammerpohl, O., von Schönfels, W., Ahrens, M., Heits, N., Bell, J. T., Tsai, P.-C., Spector, T. D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412759111 · Cited by 766
Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 720
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603
Hepatic histology in obese patients undergoing bariatric surgery
Machado, M., Marques-Vidal, P., & Cortez-Pinto, H. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.013 · Cited by 583
Simmonds, M. C., Higginsa, J. P. T., Stewartb, L. A., Tierneyb, J. F., Clarke, M. J., & Thompson, S. G. (2005) · Clinical Trials · doi:10.1191/1740774505cn087oa · Cited by 555
American Society of Clinical Oncology Position Statement on Obesity and Cancer
Ligibel, J. A., Alfano, C. M., Courneya, K. S., Demark-Wahnefried, W., Burger, R. A., Chlebowski, R. T., Fabian, C. J., Gucalp, A., Hershman, D. L., Hudson, M. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.4680 · Cited by 526
Pathological Features of Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.056 · Cited by 346
Non-alcoholic fatty liver disease
Sattar, N., Forrest, E., & Preiss, D. (2014) · BMJ · doi:10.1136/bmj.g4596 · Cited by 325
du Plessis, J., van Pelt, J., Korf, H., Mathieu, C., van der Schueren, B., Lannoo, M., Oyen, T., Topal, B., Fetter, G., Nayler, S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.044 · Cited by 325
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
Suzuki, A., Lindor, K., Saver, J. S., Lymp, J., Mendes, F., Muto, A., Okada, T., & Angulo, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.008 · Cited by 319
Tilg, H., Moschen, A. R., & Szabo, G. (2016) · Hepatology · doi:10.1002/hep.28456 · Cited by 319
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
Chavez-Tapia, N. C., Tellez-Avila, F. I., Barrientos-Gutierrez, T., Mendez-Sanchez, N., Lizardi-Cervera, J., & Uribe, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007340.pub2 · Cited by 297
Klein, S., Mittendorfer, B., Eagon, J. C., Patterson, B., Grant, L., Feirt, N., Seki, E., Brenner, D., Korenblat, K., & McCrea, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.042 · Cited by 289
Zelber-Sagi, S., Lotan, R., Shlomai, A., Webb, M., Harrari, G., Buch, A., Nitzan Kaluski, D., Halpern, Z., & Oren, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.011 · Cited by 277
Koehler, E. M., Schouten, J. N. L., Hansen, B. E., van Rooij, F. J. A., Hofman, A., Stricker, B. H., & Janssen, H. L. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.028 · Cited by 251
Zimmermann, E., Gamborg, M., Holst, C., Baker, J. L., Sørensen, T. I. A., & Berentzen, T. L. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006998 · Cited by 213
Bruno, S., Maisonneuve, P., Castellana, P., Rotmensz, N., Rossi, S., Maggioni, M., Persico, M., Colombo, A., Monasterolo, F., Casadei-Giunchi, D., et al. (2005) · BMJ · doi:10.1136/bmj.38391.663287.e0 · Cited by 201
Non‐alcoholic fatty liver disease from pathogenesis to management: an update
Musso, G., Gambino, R., & Cassader, M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00657.x · Cited by 196
Xu, C., Yu, C., Ma, H., Xu, L., Miao, M., & Li, Y. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.104 · Cited by 182
Wong, V. W.-S., Wong, G. L.-H., Yeung, D. K.-W., Lau, T. K.-T., Chan, C. K.-M., Chim, A. M.-L., Abrigo, J. M., Chan, R. S.-M., Woo, J., Tse, Y.-K., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.041 · Cited by 173
Metabolically healthy and unhealthy obese – the 2013 Stock Conference report
Samocha‐Bonet, D., Dixit, V. D., Kahn, C. R., Leibel, R. L., Lin, X., Nieuwdorp, M., Pietiläinen, K. H., Rabasa‐Lhoret, R., Roden, M., Scherer, P. E., et al. (2014) · Obesity Reviews · doi:10.1111/obr.12199 · Cited by 169
Xu, C., Yu, C., Xu, L., Miao, M., & Li, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011578 · Cited by 161
Liver-spleen axis: Intersection between immunity, infections and metabolism
Tarantino, G. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i23.3534 · Cited by 158
Hashimoto, Y., Hamaguchi, M., Kojima, T., Ohshima, Y., Ohbora, A., Kato, T., Nakamura, N., & Fukui, M. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12786 · Cited by 146
Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting
Blais, P., Husain, N. S., Kramer, J. R., Kowalkowski, M. A., El‐Serag, H. B., & Kanwal, F. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.134 · Cited by 140
Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease
Sourianarayanane, A., Garg, G., Smith, T. H., Butt, M., McCullough, A. J., & Shen, B. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.10.015 · Cited by 139
A population-based study on the prevalence of NASH using scores validated against liver histology
Hyysalo, J., Männistö, V., Zhou, Y., Arola, J., Kärjä, V. J., Leivonen, M., Juuti, A., Jaser, N., Lallukka, S., Käkelä, P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.009 · Cited by 132
Li, H., Dong, K., Fang, Q., Hou, X., Zhou, M., Bao, Y., Xiang, K., Xu, A., & Jia, W. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.029 · Cited by 129
Spleen: A new role for an old player?
Tarantino, G. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i33.3776 · Cited by 123
Roles of alcohol consumption in fatty liver: A longitudinal study
Moriya, A., Iwasaki, Y., Ohguchi, S., Kayashima, E., Mitsumune, T., Taniguchi, H., Ando, M., & Yamamoto, K. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.025 · Cited by 114
Mulder, P., Morrison, M. C., Wielinga, P. Y., van Duyvenvoorde, W., Kooistra, T., & Kleemann, R. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.226 · Cited by 108
Lee, J. W., Cho, Y. K., Ryan, M. C., Kim‡, H., Lee, S. W., Chang, E., Joo, K. J., Kim∥, J. T., Kim¶, B. S., & Sung, K. (2010) · Gut and Liver · doi:10.5009/gnl.2010.4.3.378 · Cited by 92
Miyake, T., Kumagi, T., Hirooka, M., Furukawa, S., Koizumi, M., Tokumoto, Y., Ueda, T., Yamamoto, S., Abe, M., Kitai, K., et al. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0650-8 · Cited by 90
Wu, L., Parekh, V. V., Hsiao, J., Kitamura, D., & Kaer, L. V. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324052111 · Cited by 83
Kim, N. H., Kim, J. H., Kim, Y. J., Yoo, H. J., Kim, H. Y., Seo, J. A., Kim, N. H., Choi, K. M., Baik, S. H., Choi, D. S., et al. (2014) · Liver International · doi:10.1111/liv.12454 · Cited by 81
Yu, D., Shu, X., Xiang, Y., Li, H., Yang, G., Gao, Y., Zheng, W., & Zhang, X. (2014) · Journal of Nutrition · doi:10.3945/jn.114.197533 · Cited by 79
Verbeek, J., Lannoo, M., Pirinen, E., Ryu, D., Spincemaille, P., Elst, I. V., Windmolders, P., Thevissen, K., Cammue, B. P. A., van Pelt, J. F., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-306748 · Cited by 79
Zelber‐Sagi, S., Salomone, F., Yeshua, H., Lotan, R., Webb, M., Halpern, Z., Santo, E., Oren, R., & Shibolet, O. (2013) · Liver International · doi:10.1111/liv.12318 · Cited by 74
Zhang, T., Zhang, C., Zhang, Y., Tang, F., Li, H., Zhang, Q., Lin, H., Wu, S., Liu, Y., & Xue, F. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.049 · Cited by 73
Hyperinsulinemia and the Development of Nonalcoholic Fatty Liver Disease in Nondiabetic Adults
Rhee, E., Lee, W., Cho, Y.-K., Kim, B.-I., & Sung, K. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.08.012 · Cited by 70
Kim, H., Lee, G. E., Jeon, S.-H., Kim, J.-H., Park, J., Lee, K., & Kim, C. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181812879 · Cited by 67
Musso, G., Bo, S., Cassader, M., Michieli, F. D., & Gambino, R. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.063792 · Cited by 54
Association between metabolic syndrome and the development of non-alcoholic fatty liver disease
Wang, Y., Li, Y. Y., Nie, Y. Q., Zhou, Y. J., Cao, C. Y., & Xu, L. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1090 · Cited by 51
Bariatric surgery for curing NASH in the morbidly obese?
Lassailly, G., Caiazzo, R. J., Pattou, F. N., & Mathurin, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.026 · Cited by 47
The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women
Chung, G. E., Yim, J. Y., Kim, D., Lim, S. H., Yang, J. I., Kim, Y. S., Yang, S. Y., Kwak, M., Kim, J. S., & Cho, S. (2015) · BioMed Research International · doi:10.1155/2015/131528 · Cited by 46
Miyake, T., Kumagi, T., Furukawa, S., Hirooka, M., Kawasaki, K., Koizumi, M., Todo, Y., Yamamoto, S., Tokumoto, Y., Ikeda, Y., et al. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0989-0 · Cited by 45
Insights into obesity and diabetes at the intersection of mouse and human genetics
Kebede, M. A., & Attie, A. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.06.006 · Cited by 38
García‐Monzón, C., Vargas‐Castrillón, J., Carro, J. L. P., Alonso, M. T., Bonachía, Ó., Castillo, M. J., Marcos, A., Quirós, E., Ramos, B., Sánchez‐Cabezudo, C., et al. (2015) · Liver International · doi:10.1111/liv.12813 · Cited by 36
Predictive Factors for the Development or Regression of Fatty Liver in Japanese Adults
Omagari, K., Morikawa, S.-I., Nagaoka, S., Sadakane, Y., Sato, M., Hamasaki, M., Kato, S., Masuda, J., Osabe, M., Kadota, T., et al. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.08-269 · Cited by 21
[The association between body mass index and non-alcoholic fatty liver disease].
Yu, X., Zhao, Y., Song, X., & Song, Z. (2014) · PubMed · doi:10.3785/j.issn.1008-9292.2014.09.010 · Cited by 6
Research works printed but not linked: 3
- Manco M, 2014, Population‐based screening programs for nonalcoholic fatty liver disease in youth and clues to prevention, J Clin Endocrinol Metab, 99, 774, 10.1210/jc.2014-1290 · doi:10.1210/jc.2014-1290
- 10.1016/j.ajg.2014.05.002 · doi:10.1016/j.ajg.2014.05.002
- 10.1038/ajg.2014.207 · doi:10.1038/ajg.2014.207
Cited by
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Epidemiological Features of NAFLD From 1999 to 2018 in China
Zhou, J., Zhou, F., Wang, W., Zhang, X., Ji, Y., Zhang, P., She, Z., Zhu, L., Cai, J., & Li, H. (2020) · Hepatology · doi:10.1002/hep.31150 · Cited by 678
Wong, V. W., Chan, W., Chitturi, S., Chawla, Y., Dan, Y. Y., Duseja, A., Fan, J., Goh, K., Hamaguchi, M., Hashimoto, E., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13857 · Cited by 506
Eslam, M., Alkhouri, N., Vajro, P., Baumann, U., Weiss, R., Socha, P., Marcus, C., Lee, W. S., Kelly, D., Porta, G., et al. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00183-7 · Cited by 281
Qiu, Y.-Y., Zhang, J., Zeng, F.-Y., & Zhu, Y. Z. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106786 · Cited by 271
Metadata
- Authors
- Li, L., Liu, D. ‐., Yan, H. ‐., Wang, Z. ‐., Zhao, S. ‐., & Wang, B.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2016-03-28
- Volume
- 17
- Issue
- 6
- Pages
- 510-519
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W2328891011
- Cited by
- 439
- References
- 65
- FWCI
- 20.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.